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Abstract
Background: Stroke often results in chronic disability, with partners and family members taking on the role of
informal caregiver. There is considerable uncertainty regarding how best to identify and address carers’ needs. The
Carer Support Needs Assessment Tool (CSNAT) is a carer-led approach to individualised assessment and support for
caregiving that may be beneficial in palliative care contexts. CSNAT includes an implementation toolkit. Through
collaboration, including with service users, we adapted CSNAT for stroke and for use in a UK stroke specialist organisation
providing long-term support. The main aims of OSCARSS are to investigate the clinical and cost-effectiveness
of CSNAT-Stroke relative to current practice. This paper focuses on the trial protocol, with the embedded
process evaluation reported separately.
Methods: Longitudinal, multi-site, pragmatic, cluster randomised controlled trial with a health economic analysis.
Clusters are UK services randomised to CSNAT-Stroke intervention or usual care, stratified by size of service. Eligible
carer participants are: adults aged > 18 years; able to communicate in English; referred to participating clusters; and
seen face-to-face at least once by the provider, for support. The ‘date seen’ for initial support denotes the start of
intervention (or control) and carers are referred to the research team after this for study recruitment. Primary outcome
is caregiver strain (FACQ - Strain) at three months after ‘date seen’. Secondary outcomes include: caregiver distress;
positive caregiving appraisals (both FACQ subscales); Pound Carer Satisfaction with Services; mood (HADs); and health
(EQ-5D5L) at three months. All outcomes are followed up at six months. Health economic analyses will use additional
data on caregiver health service utilisation and informal care provision.
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Discussion: OSCARSS is open to recruitment at the time of article submission. Study findings will allow us to evaluate
the clinical and cost-effectiveness of the CSNAT-Stroke intervention, directed at improving outcomes for informal carers
of stroke survivors. Trial findings will be interpreted in the context of our embedded process evaluation including
qualitative interviews with those who received and provided services as well as data on treatment fidelity.
OSCARSS will contribute to knowledge of the unmet needs of informal stroke caregivers and inform future
stroke service development.
Trial registration: ISRCTN Registry, ISRCTN58414120. Registered on 26 July 2016.
Keywords: Cluster randomised controlled trial, Informal caregivers, Carers, Stroke, Complex intervention, Health
service; service user involvement; health economics; qualitative interviews
Background
Stroke causes a greater range of disabilities than any
other chronic condition in the UK [1]. Stroke survi-
vors experience loss of abilities and independence and
express concerns about how their condition impacts
their partners and family members, who often take on
the role of informal caregiver to support personal
care and daily living [2, 3]. In the UK alone, informal
caregivers for stroke provide care worth up to £2.5
billion per year [4, 5]. This can come at a great per-
sonal cost to informal carers, threatening their phys-
ical health, connection with family and social
networks, finances and emotional wellbeing [6–9].
Identifying and addressing the needs of informal
caregivers is a priority at a national level [10–12].
However, several Cochrane reviews highlight consider-
able uncertainty regarding how best to support stroke
caregivers [13–15]. Research suggests that a ‘one-size
fits all’ approach to assessment and support is not as
beneficial as support that is most closely matched to
individuals’ current and specific needs, priorities and
preferences [16, 17].
The Carer Support Needs Assessment Tool
(CSNAT) intervention [18] is a comprehensive
carer-led approach to individualised assessment and
support that was developed in the context of pallia-
tive care. It includes a staff training package and im-
plementation toolkit. The CSNAT intervention
appeared to reduce carer strain in a community pal-
liative care context, when compared to a control of
usual care in a before / after stepped wedge design
[19]. It also appeared to improve carer psychological
and physical health in bereavement in a UK stepped
wedge trial [20]. In these pragmatic studies, no
changes were made to other support services avail-
able for carers between control and intervention pe-
riods. Qualitative work with carers [21] and
practitioners [22] suggested that CSNAT was highly
valued by both groups and made best use of avail-
able resources and time when identifying and priori-
tising needs and supporting carers.
We adapted the original CSNAT intervention and
training package for implementation in stroke prac-
tice, collectively named CSNAT-Stroke. The adapta-
tion was carried out through close collaboration with
carers and a UK stroke service provider organisation.
A study-specific Research User Group (RUG) of indi-
viduals with experience of caring for a stroke sur-
vivor, was set up for OSCARSS and they support
study development through regular meetings and
representation on the Trial Management Group
(TMG). They continue to input to study manage-
ment while the trial is open to recruitment and
thereafter will contribute to interpretation and dis-
semination of the findings.
In terms of service provider collaborators, a work-
ing group of senior Stroke Association staff and their
Training and Development department collaborated
in development of the staff training and implementa-
tion approach used in OSCARSS. The Stroke Associ-
ation is a stroke specialist provider service with over
200 stroke support services throughout the UK. Ser-
vices are organised flexibly to meet requirements of
the local population; practice therefore varies across
different services according to availability and prefer-
ences. Many services are embedded in hospitals and
referrals for support are primarily received from the
National Health Service (NHS) soon after the stroke
event; although individuals can be referred – or
self-refer – at any time after stroke. All OSCARSS re-
search sites/clusters are drawn from Stroke Associ-
ation services.
Trial aim and research questions
The primary aim of OSCARSS is to determine the ef-
fectiveness of the CSNAT-Stroke intervention for carers
of stroke survivors, when compared to a usual care con-
trol. The primary research question is: does the inter-
vention reduce caregiver strain (as measured by the
strain subscale of the Family Appraisal of Caregiving
Questionnaire (FACQ) [23]), when compared to control?
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Secondary research questions address whether the
intervention:
 reduces perceived caregiver distress (subscale of
FACQ) [23];
 improves: carer perceptions of their health (EQ-
5D-5 L) [24] and wellbeing (Hospital Anxiety and
Depression Scale (HADS) [25]; positive caregiving
appraisals (subscale of FACQ) [23]; and
satisfaction with services (Pound Scale) [26];
 leads to less economic burden for carers and society
(as measured by an adapted version of the Service
Receipt Inventory [27] that records use of health
services and informal care provision).
Methods
OSCARSS is a longitudinal, pragmatic multi-site cluster
randomised controlled trial (cRCT) with a health eco-
nomic analysis and nested process evaluation. Cluster
randomisation is essential to avoid contamination as we
are evaluating delivery of an intervention within a ser-
vice, sometimes by a team.
Not described in detail in this protocol is an em-
bedded process evaluation that includes survey data,
service delivery records and qualitative data. In brief,
data collected from service providers (staff and man-
agers) will explore intervention implementation and
workforce behaviour change. Interviews with service
recipients (carer research participants) will explore
their experiences of support (intervention or control)
and the types of support inputs identified and priori-
tised by them. Figure 1 shows these parallel compo-
nents of OSCARSS but the cRCT and health
economics are the focus of this paper. The process
evaluation, which will be invaluable in providing the
context for interpretation of the trial findings, will be
described elsewhere.
A Standard Protocol Items: Recommendations for
Interventional Trials (SPIRIT) checklist is provided as
Additional file 1.
Fig. 1 Outline of the OSCARSS study process. For contextual information, this figure includes cRCT processes (middle) as well as components of
the embedded process evaluation: carer interviews (dotted line boxes within middle figure); staff and manager surveys and interviews (left)
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Trial clusters: inclusion criteria and randomisation
Eligible clusters are defined as UK stroke specialist pro-
vider services that:
 include face-to-face contact with carers (excluded
are services that only provide telephone support);
 have capacity to engage in OSCARSS (excluded are
services participating in any other stroke carer-related
research);
 are likely to have at least five new client referrals per
month. Clients include both stroke survivors (who
are likely to have associated carers) and carers
directly. This ensures that a new system of working
can be operationalised and well-established and that
research resources required for training and
monitoring sites are justified;
 are independent of other clusters. If staff across
services shared client caseloads, they would be
aggregated to form one cluster to avoid the risk
of between-group contamination. Conversely,
individual staff within services could form
independent clusters if they work independently,
without sharing caseloads.
Clusters are recruited by the CLAHRC GM research
team before randomisation, to ensure allocation conceal-
ment. Clusters are block randomised to intervention or
control at the ‘site’ level with dichotomised stratification
for ‘size of service’ (high / low -based on historic data
about client caseloads) using random blocks. Neither the
clusters nor the researchers know the block sizes when
recruiting sites. The trial statistician is provided with an
anonymised list of recruited clusters and randomises them
using STATA programme, including the ‘ralloc’ add-on.
The research team is blinded to allocation as far as
possible, but front-line team members could become
unblinded when observing staff training (delivered
after randomisation) or when supporting sites to en-
gage in the study.
Carer research participants are blind to allocation;
they receive support by the provider organisation in
both arms of the trial, but the nature of support is
different according to allocation to research interven-
tion or control. Carers are not consenting to random-
isation but to follow-up.
Intervention
The CSNAT-Stroke is the research intervention, de-
scribed briefly here. All intervention materials, including
training handbook and instructional videos, will be made
available after the trial when treatment fidelity and ad-
herence will be reported.
CSNAT-Stroke provides a structured, standardised ap-
proach to offering an evidence-based needs assessment
for carers, which is distinct from the stroke survivor. It
involves the use of a single-page assessment tool orga-
nised into broad domains of need and a written action
plan for review. CSNAT-Stroke is predicated on staff be-
haviour change and follows a general process that can be
flexibly applied whenever the staff member has contact
with a carer. It is facilitated by a staff training and imple-
mentation package. CSNAT-Stroke promotes a carer-led,
practitioner-facilitated approach to identifying and
implementing support inputs that are directly derived
from the needs assessment. Table 1 summarises the
intervention process with Fig. 2 as a basic visual repre-
sentation of the intervention. As described in our dis-
semination plan, we will report using the Template for
Table 1 Summary of CSNAT-Stroke intervention
Step Description Timing and duration Mode
Introduction Carers identified and assured that support is
available
Point of referral to service; ≈ 5 min
duration
Telephone or face-to-face
(inpatient settings or
home), depending on
referral
Carers consider
needs
CSNAT-Stroke needs assessment tool introduced.
Carers encouraged to take independent time to
consider and complete, indicating domains in which
they need more support
At the point of contact; ≈ 5 min duration Face-to-face (may be sent
by post for follow-ups)
Assessment
conversation
Using the CSNAT-Stroke tool as a ‘conversation
ramp’, carers supported to prioritise the domains
most important to them currently: to identify their
individual needs within those domains and the type
of supportive input they would find helpful. Support
may be directly delivered by practitioner at this time
(e.g. reassurance and information) but family
support, signposting or referral to other agencies
may also be included
During support contact. Duration dictated
by time available; ≈ minimum 10min, with
‘set up’ regarding time available to manage
expectations
Typically face-to-face but
possible by phone for
follow-up contact
Shared action and
review plan
Actions to address needs are recorded on a paper
tool and, if appropriate, a plan is agreed regarding
review / update on actions carried out
Following assessment conversation Carers given hard copy
action plan. Staff records in
service database
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Intervention Description and Replication (TIDieR)
guidelines [28].
Carer research participants: inclusion criteria and
recruitment processes
Adult (aged > 18 years) informal carers of stroke survi-
vors are eligible if they:
 are referred to participating clusters;
 receive at least one face-to-face support contact
(regardless of the resultant level of support / need,
e.g. support may be a single face-to-face visit, with
follow-up support by telephone);
 are able to communicate in English (facilitated by
supportive communication techniques); and
 are ‘active’ in their caring role at the time of study
entry, i.e. the stroke survivor being cared for is alive.
Following the first face-to-face contact, i.e. after sup-
port has been delivered according to intervention or
control, staff provide a brief OSCARSS information leaf-
let and ask carers if they would like to be referred to the
research team to find out more about potential study
participation. Carers are told that the service is being
evaluated, but they are not told about the randomised
trial (blinding). The opportunity for study referral is of-
fered, even if a carer does not go on to receive further
support from the service. Carers can be given up to six
weeks to decide about study referral.
If carers accept referral, their details are securely passed
to the research team who make first contact by phone,
introducing the study and providing full study information
by post to seek consent. This process ensures a clear separ-
ation between the research and the provision of support (ei-
ther research intervention or control).
Informed consent is sought by researchers trained in
Good Clinical Practice (GCP) and using approved docu-
ments for information and consent, which were
co-designed with carers via the OSCARSS RUG. Partici-
pant information and consent materials are available on
request from the authors and will be published at trial
end. The right to refuse participation without giving rea-
sons is respected and research participants remain free
to withdraw at any time from the study without giving
reasons and without prejudicing further support.
Data collection
The schedule of data collection and the outcome mea-
sures to be collected are shown in Fig. 3, the SPIRIT
figure, with more detail below.
Carer self-report measures
Demographic and clinical characteristics, related to the
carers and their cared-for stroke survivors, are collected
at study entry, along with EQ-5D-5 L [24]. These data
are not strictly speaking baseline, as support (either
intervention or control) has already been initiated at the
point of study referral. Staff provide a ‘date first seen’
when referring carers to the study and this is considered
the ‘start date’ for intervention or control.
Initial and follow-up outcomes are sought three and
six months after ‘start date’, respectively. The time dif-
ference between study entry and outcomes collection
will not necessarily be exactly three and six months,
Fig. 2 Basic visual representation of the CSNAT-Stroke intervention
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since the recruitment process takes some time after
referral (and, as above, referrals can be received up to
six weeks from ‘start date’). In cases where carers re-
quest more time to make a decision about consent,
study entry data and three-month outcomes can be
collected simultaneously. To allow sufficient time for
reminders and return post, initial outcomes can be
returned any time up to 4.5 months from ‘start date’.
Follow-up outcome data are sought at six months
and can be returned any time up to 7.5 months from
‘start date’. Due to the study end date, we can only
collect six-month (secondary) outcomes up to month
27. A study database auto-generates all prompts for
data collection and, to improve retention, phone calls
engage participants before any postal packs are sent.
Thank you notes also advise when participation is
noitacollAtnemlornE
through 
cluster 
random-
isation 
Post-
enrolment 
Carer recruitment and data collection 
period (months) 
TIMEPOINT -10 to 0 
months 
0 Month 3 Recruit
18 months 
(4 to 22) 
3 month 
outcomes 
(7 to 25) 
6 month 
outcomes 
(10 to 27#)
 CLUSTER ENROLMENT: 
Cluster identification and 
eligibility screen  
X  
Cluster Randomisation   X 
Cluster training   X
CARER ENROLMENT  
INTERVENTIONS: 
CSNAT-Stroke for carer support 
Standard practice carer support 
ASSESSMENTS (postal 
questionnaire): 
Demographic & clinical info    X   
EQ-5D 5L†    X X X 
Caregiver Strain subscale of 
FACQ
X* X 
Caregiver distress subscale of 
FACQ
    X X 
Positive caregiving appraisals 
subscale of FACQ 
    X X 
Pound Satisfaction with Stroke 
Services  
    X X 
HADS     X X 
Service Receipt Inventory  
(& time spent caring)†
    X X 
*Primary outcome (caregiver strain subscale of FACQ at 3 month outcomes collection)
† Health Economics related 
# Due to overall study duration, data collection for six month (secondary) outcomes will end in month 27
Fig. 3 SPIRIT figure
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complete and that a final report on results will be
sent at study close (see ‘Dissemination plan’).
All measures are described below and are completed
by carers via self-report postal questionnaire. Carers are
given the option to complete over the phone with tele-
phone support from a researcher:
 FACQ [23]: the caregiver strain (primary outcome
at the three-month collection point) and caregiver
distress subscales assess the negative impact of
caring, while the positive appraisals subscale assess
the positive impact of caring. The strain subscale of
FACQ was used to successfully evaluate the
effectiveness of the original CSNAT in a palliative
care context [19] and is chosen as the primary clinical
endpoint as it directly addresses the primary research
aims. In addition, the OSCARSS RUG agreed that
caregiver strain was most likely to be alleviated
through this intervention and felt that, when compared
to other candidate caregiver strain or burden scales,
FACQ was more relatable and more likely to be
completed through postal questionnaire;
 caregiver’s perceived quality of support and satisfaction
with services will be assessed using the Pound Carer
Satisfaction with Stroke Services Scale [26];
 carer wellbeing and health will be assessed using the
HADS [25] and EQ-5D-5 L [24], respectively;
 for health economic analysis, an adapted version of
the Service Receipt Inventory [27] will record use of
health, social care and third sector services, as well as
the amount and nature of informal care provision.
Service delivery records
Staff with access to the clusters’ in-house data management
systems will securely provide study-specific data to the re-
search team for consented carers. This will include: the
dates, types and durations of support contacts delivered; and
standardised entries from staff pertaining to needs identified
and actions taken during support contacts. Support contacts
include both direct and non-direct contact (e.g. liaison with
external agents). Health economics analysis will include ‘ser-
vice delivery costs’ for each consented carer, based on these
data, by valuing support time using service provider full
costs. As well as data specific to consented carers, the re-
search team will be securely provided with fully anonymised
service delivery records for all clients in participating ser-
vices / clusters (intervention and control). These records will
contain no personal client data but will include: the number,
duration and type of contacts completed by coordinators;
and categories of needs identified and actions completed.
These data will support an economic understanding of
whole service delivery across participating clusters (compar-
ing intervention to control) and an exploration of how rep-
resentative OSCARSS participants are of all cluster clients.
Sample size
The primary outcome is the Caregiver Strain subscale
of the FACQ [23] at three months after intervention /
control (see also Fig. 3). This subscale scale consists of
eight questions, each worth a maximum of 5 points,
and can be reported as a mean score per question
(maximum score = 5.0) or total number of points (max-
imum score = 40 points). Cooper et al. [23] reported a
mean (SD) of 3.13 (0.87) on this subscale on a study of
160 participants. In their trial to assess the impact of
the CSNAT intervention in the palliative care setting,
Aoun [19] reported a standardised effect size on the
FACQ caregiver strain subscale of 0.348 which corre-
sponds to a difference of 0.31 on the mean score. Based
on empirical data from similar settings, we do not ex-
pect the intraclass correlation coefficient (ICC) to be >
0.05 (https://www.abdn.ac.uk/hsru/what-we-do/tools).
In fact, TRACS, a cluster randomised trial which
trained carers to provide care to stroke survivors [27],
reported ICCs of 0.013 for caregiver burden.
Table 2 shows the sample sizes to achieve 80%
power, assuming at least 16 active clusters per arm
and SD = 0.9.
Our minimum target is 320 carers providing pri-
mary outcomes at three months. This would allow
us 80% power to detect effect sizes of 0.31 or more
for ICCs ≤ 0.01, and effect sizes of ≥ 0.375 for ICCs
of ≤ 0.05. We assume a retention rate of 80% be-
tween consent and primary outcomes, which means
we require a minimum of 400 consented carers.
An optimum sample size of 512 (640 consented carers)
would allow us 80% power to detect effect sizes of ≥ 0.31
for ICCs ≤ 0.05 and would allow us to detect effect sizes of
≤ 0.25 for an ICC of 0.01. We would cease recruitment if
we hit this figure before the planned recruitment end date.
Sample size calculations were carried out using the
clsampsi function in STATA.
Statistical analysis
Adverse events
This study’s intervention is low risk, primarily involving
staff behaviour change when supporting carers within
their role. Serious adverse events (SAEs) are an inherent
Table 2 Sample size projections
ICC Effect size = 0.31 unit change
in mean score (2.5 points
change on total score)
0 288
0.01 320
0.025 384
0.05 512
0.075 800
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part of an active caregiving role (e.g. musculoskeletal in-
jury; new medical problems or deterioration of existing
medical problems, including depression). It is possible
that these could lead to hospitalisation, prolongation of
existing hospitalisation, disability / incapacity or death.
As such, they are expected SAEs; there are no SAEs that
we predict will be related to the research intervention.
All adverse events (AEs) will be recorded. SAEs will be
reported to the Research Ethics Committee (REC) within
15 days if the Chief Investigator believes they might be
related to the research and unexpected.
Analysis, including economic evaluation
A full and detailed statistical analysis plan (SAP), includ-
ing information on how any missing data will be man-
aged, is included as an Additional file 2.
Analysis of the primary outcome comparing interven-
tion and control at three months will be carried out on
the basis of intervention to treat (ITT) and performed
using a multilevel regression model, with a random
intercept for ‘site’ to take into account clustering and a
fixed covariate for ‘intervention’ along with adjustment
using the following fixed individual level covariates:
stroke severity of cared-for person (as rated by carer),
time post-stroke, age of carer, health of carer at study
entry (as indicated by self-reported pre-existing
long-term health conditions) and the following cluster
level covariates; size of service, pre-existing knowledge/
experience of staff delivering support. By the design of
this cluster randomised trial, recruitment of individual
carers takes place after randomisation and therefore we
are at risk of selection bias. We plan to adjust for base-
line covariates in an attempt to control for any baseline
imbalance. Similar analysis will be used for all numeric
secondary outcome measures.
The mean number of carers per cluster, the mean num-
ber of support contacts per carer per cluster and the mean
duration of contacts per carer per cluster will be compared
between control and intervention groups using t-tests. We
would not expect these variables to have appropriate distri-
butions for analysis using a linear mixed model.
Sensitivity analyses will explore any potential bias in
the analysis of the primary outcome measure and exam-
ine how robust the findings are:
i. without adjustment for covariates;
ii. per protocol;
iii. combining three-month and six-month month data:
using ‘time’ and ‘time by group interaction’ as fixed
covariates, all available three-month and six-month
data will be combined for the Caregiver Strain
subscale of the FACQ. This will allow us to
explore how caregiver strain changes over time
and whether any effect of the intervention
changes over time;
iv. multiple imputation: using multiple imputation to
replace missing values on the primary outcome
measure using the following covariates: stroke
severity of cared-for’s stroke; time after stroke;
age of carer; pre-stroke health of carer (as per
Royston [29]);
v. excluding delayed responses: excluding any data
from individuals who return their three-month
outcome data later than 4.5 months after ‘date seen’
or six-month outcome data later than 7.5 months
after ‘date seen’;
vi. removing carer dyads: where multiple carers of the
same stroke survivor have provided outcome data;
excluding data from the second and subsequent
carers linked to the same stroke survivor.
Data relevant to the Health Economics analysis will in-
clude the Service Receipt Inventory, number of support
contacts delivered per carer, informal care provision esti-
mates and EQ-5D-5 L. Trial health economists will at-
tach costs to questionnaire items and support contacts
to allow a comparison across research intervention and
control arms of the trial. Prognostically important vari-
ables such as carer health and demographics will be fac-
tored into an analysis comparing use of healthcare
services, with severity of stroke survivor factored in to
an analysis comparing time spent caring.
Data management and monitoring
All information collected is kept strictly confidential. In-
formation will be held securely on paper in locked filing
cabinets and electronically on encrypted servers. All data
are anonymised as early as possible, with carers assigned
a unique identifier as soon as they are entered into the
database. If a participant withdraws consent at any time,
their research data will remain on file and will be in-
cluded in the final study analysis, unless otherwise re-
quested. If a withdrawing participant agrees to receive a
final report summarising the results of the study, their
contact information will be held on file for these pur-
poses and will be deleted once the final report is sent.
Standard Operating Procedures (SOP) for data entry
processes ensure consensus in interpreting ambiguous
data. The SOP also outlines data checking for quality
and is available on request. Delegation logs determine
which study staff are trained and assured to carry out
specific tasks, including data entry.
The Research Team will form a Trial Management
Group (TMG) and a Trial Steering Committee (TSC).
The TSC will be chaired by and include independent
members as well as key trial personnel. Data to be regu-
larly monitored will include: individual level study-entry
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demographic and clinical variables; and cluster level data
related to referrals and recruitment. The TMG and TSC
will consider recruitment and balance across the inter-
vention and control arms throughout the study. After
four months of carer recruitment, the TSC met to con-
sider these data to make a recommendation as to
whether the trial should be allowed to continue, con-
tinue with modification or be discontinued (they decided
on the former). A TSC charter outlining roles and re-
sponsibilities is available on request.
Discussion
This paper describes the protocol for a novel trial ex-
ploring clinical and cost-effectiveness of a pragmatic
intervention to support and empower informal carers of
stroke survivors. It differs from TRACS [27] in that
OSCARSS trains staff to support carers’ own needs
whereas the focus of TRACS was to train carers to per-
form the caring role. The OSCARSS intervention has
been adapted from an existing approach used success-
fully in palliative care settings.
All aspects of the study have been designed in collab-
oration with key stakeholders, including carers them-
selves who form our study specific RUG, and stroke
professionals who deliver the support. We believe this
collaboration strengthens the study, including optimising
recruitment processes and outcome measurement.
There are also some challenges to address, including the
lack of baseline measures to explore change in outcomes,
which the randomised design helps overcome. In terms of
outcomes, the majority of our clinical endpoint data will
be based on carer self-report, using measures that have
been carefully selected through consultation with litera-
ture and co-development with service users. The interven-
tion aims to provide individualised carer support and
reduce the negative impact of caregiving, but our carer eli-
gibility criteria are extremely inclusive and do not require
diagnosis of depression, anxiety or similar. As such, hard
clinical endpoints requiring professional assessment would
be inappropriate in this pragmatic trial.
The decision to widen the time window for returning
the postal questionnaire is a pragmatic one but may in-
crease variability in when we measure outcomes. This
will be adjusted for, as needed, with sensitivity analysis.
Cluster randomisation is essential to avoid contamin-
ation as we are evaluating delivery of an intervention
within a service but leads to potential for differential re-
cruitment as allocation is known in advance of consent.
Methods to overcome this have been outlined above and
in the SAP but in addition, all cluster staff are given simi-
lar training with regards to recruitment and record keep-
ing and are regularly engaged with by the research team
and service managers to encourage consistent referrals to
the study. Generalisability will be explored through
comparing characteristics of our sample to anonymised
data related to national caseloads of the service provider.
This paper has focused on the cRCT and health econom-
ics, but it is strengthened by an embedded mixed-methods
process evaluation to ensure a contextualised interpretation
of our findings. The process evaluation will be described
fully elsewhere but includes: implementation of the re-
search into practice; sustainability of the research interven-
tion; and the effect of research team on staff behaviour.
The research intervention requires staff behaviour change
and the pragmatic design leads to anticipated challenges ex-
ploring intervention fidelity, which the process evaluation
will also help overcome. Semi-structured qualitative inter-
views will explore staff and carer experiences of delivering
and receiving support, respectively. Interviews are com-
pleted with purposively sampled participants, considering
demographic variables, arm allocation and geographical lo-
cation. Interviews and focus groups will also be completed
with service provider managers and senior leadership
teams. The process evaluation is overseen by expert imple-
mentation and qualitative researchers who were not in-
volved in the trial design.
Overall, OSCARSS will provide pragmatic data on fu-
ture healthcare development for supporting carers of
stroke survivors. Health economics components will
allow exploration of costs with a view to providing a
costed service specification to directly inform service im-
provements. The model for adapting and implementing
the research intervention through collaboration could be
applied to other health conditions and settings.
Dissemination plan
The findings from OSCARSS will be published in
scientific journals using the following guidelines: Consoli-
dated Standards of Reporting Trials (CONSORT) guide-
lines for cRCTs [30]; Template for Intervention
Description and Replication (TIDieR) guidelines for inter-
vention description [28]; and Consolidated criteria for
reporting qualitative research (COREQ) guidance for
qualitative research [31]. Trial findings will also be written
up in accessible, lay-friendly language and disseminated to
research participants and on the NIHR CLAHRC Greater
Manchester website. A study-specific event to disseminate
to all stakeholders will be held and we will disseminate to
wider audiences through local, national and international
conferences. Implementation activities will be finalised
once the results are known.
Trial status
Clusters were randomised in September 2016 and
trained in January 2017, when carer participant recruit-
ment began. The first carer was enrolled on 17 January
2017. Recruitment is ongoing (at the time of journal
submission) and will be completed by 31 July 2018.
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